RNA Formulation Solutions

  1. in vivo-jetRNA®+ 9/14/2022

    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
    in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.

  2. GenVoy-ILM™ T-Cell Kits For mRNA 4/24/2025

    Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.

  3. Automated Screening System For Lipid Nanoparticle Formulation 12/6/2024

    Transform your LNP formulation research with the IJM NanoScaler Pro, an automated screening system designed to accelerate your research and ensure the stability of your LNP samples.

  4. Plasmid DNA Manufacturing 1/31/2023

    As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.

  5. NanoAssemblr® Spark™: Freedom To Discover 4/14/2022

    The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.

  6. Small Volume Custom Media 4/1/2026

    Support early-stage bioprocess development with expedited access to small-volume custom media and buffers, backed by GMP-aligned quality systems, formulation expertise, and global consistency.

  7. Accelerating Gene Therapy With The HIT SCAN Platform 4/7/2025

    Battelle’s HIT SCAN™ platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery.

     

  8. mRNA/LNP Development And Manufacturing Services

    Messenger RNAs (mRNAs) represent a fast-emerging class of biotherapeutics. In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.

  9. Small is Powerful

    Explore best-in-class nanoforming services and how this company works with partners to find ground-breaking solutions that enhance drug effectiveness and targeting.